Sildenafil in primary pulmonary hypertension.

被引:216
作者
Prasad, S [1 ]
Wilkinson, J [1 ]
Gatzoulis, MA [1 ]
机构
[1] Royal Brompton Hosp, London SW3 6NP, England
关键词
D O I
10.1056/NEJM200011023431814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1342 / 1342
页数:1
相关论文
共 4 条
[1]  
Abrams D, 2000, Heart, V84, pE4, DOI 10.1136/heart.84.2.e4
[2]   Sildenafil ameliorates effects of inhaled nitric oxide withdrawal [J].
Atz, AM ;
Wessel, DL .
ANESTHESIOLOGY, 1999, 91 (01) :307-310
[3]   Urinary cGMP concentrations in severe primary pulmonary hypertension [J].
Bogdan, M ;
Humbert, M ;
Francoual, J ;
Claise, C ;
Duroux, P ;
Simonneau, G ;
Lindenbaum, A .
THORAX, 1998, 53 (12) :1059-1062
[4]   Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development [J].
Sanchez, LS ;
de la Monte, SM ;
Filippov, G ;
Jones, RC ;
Zapol, WM ;
Bloch, KD .
PEDIATRIC RESEARCH, 1998, 43 (02) :163-168